{"DataElement":{"publicId":"6849059","version":"1","preferredName":"Treatment Cohort Study 10287 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10287 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10287_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6849049","version":"1","preferredName":"10287 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6849049v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SG9","valueDescription":"SG9: Visceral metastasis= no,  Premenopausal / perimenopausal,  Secondary  endocrine resistance","ValueMeaning":{"publicId":"6849050","version":"1","preferredName":"SG9: Visceral metastasis= no,  Premenopausal / perimenopausal,  Secondary  endocrine resistance","longName":"6849050","preferredDefinition":"SG9: Visceral metastasis= no,  Premenopausal / perimenopausal,  Secondary  endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-55F8-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-5611-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG8","valueDescription":"SG8: Visceral metastasis= no,  Premenopausal / perimenopausal, Primary endocrine resistance","ValueMeaning":{"publicId":"6849051","version":"1","preferredName":"SG8: Visceral metastasis= no,  Premenopausal / perimenopausal, Primary endocrine resistance","longName":"6849051","preferredDefinition":"SG8: Visceral metastasis= no,  Premenopausal / perimenopausal, Primary endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-561B-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-5634-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG7","valueDescription":"SG7: Visceral metastasis = no, Postmenopausal,  Secondary  endocrine resistance","ValueMeaning":{"publicId":"6849052","version":"1","preferredName":"SG7: Visceral metastasis = no, Postmenopausal,  Secondary  endocrine resistance","longName":"6849052","preferredDefinition":"SG7: Visceral metastasis = no, Postmenopausal,  Secondary  endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-563E-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-5657-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG6","valueDescription":"SG6: Visceral metastasis = no, Postmenopausal, Primary endocrine resistance","ValueMeaning":{"publicId":"6849053","version":"1","preferredName":"SG6: Visceral metastasis = no, Postmenopausal, Primary endocrine resistance","longName":"6849053","preferredDefinition":"SG6: Visceral metastasis = no, Postmenopausal, Primary endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-5661-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-567A-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG5","valueDescription":"SG5: Visceral metastasis= yes, Premenopausal / perimenopausal,  Secondary endocrine resistance","ValueMeaning":{"publicId":"6849054","version":"1","preferredName":"SG5: Visceral metastasis= yes, Premenopausal / perimenopausal,  Secondary endocrine resistance","longName":"6849054","preferredDefinition":"SG5: Visceral metastasis= yes, Premenopausal / perimenopausal,  Secondary endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-5684-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-569D-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG4","valueDescription":"SG4: Visceral metastasis= yes, Premenopausal / perimenopausal, Primary  endocrine resistance","ValueMeaning":{"publicId":"6849055","version":"1","preferredName":"SG4: Visceral metastasis= yes, Premenopausal / perimenopausal, Primary  endocrine resistance","longName":"6849055","preferredDefinition":"SG4: Visceral metastasis= yes, Premenopausal / perimenopausal, Primary  endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-56A7-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-56C0-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG3","valueDescription":"SG3: Visceral metastasis= yes, Postmenopausal, Secondary endocrine resistance","ValueMeaning":{"publicId":"6849056","version":"1","preferredName":"SG3: Visceral metastasis= yes, Postmenopausal, Secondary endocrine resistance","longName":"6849056","preferredDefinition":"SG3: Visceral metastasis= yes, Postmenopausal, Secondary endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-56CA-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-56E3-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG2","valueDescription":"SG2: Visceral metastasis= yes, Postmenopausal, Primary endocrine resistance","ValueMeaning":{"publicId":"6849057","version":"1","preferredName":"SG2: Visceral metastasis= yes, Postmenopausal, Primary endocrine resistance","longName":"6849057","preferredDefinition":"SG2: Visceral metastasis= yes, Postmenopausal, Primary endocrine resistance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-56ED-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-5706-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"},{"value":"SG1","valueDescription":"SG1: Phase 1/Non-randomized","ValueMeaning":{"publicId":"6849058","version":"1","preferredName":"SG1: Phase 1/Non-randomized","longName":"6849058","preferredDefinition":"SG1: Phase 1/Non-randomized","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-5710-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FF192E1-5729-2D9A-E053-F662850A4951","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"ONEDATA","dateModified":"2019-08-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF192E1-55E1-2D9A-E053-F662850A4951","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"SOKKERL","dateModified":"2019-08-13","changeDescription":"Curated for Protocol 10287. ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patient Subgroup","type":"Preferred Question Text","description":"Patient Subgroup","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FF17346-FB46-305E-E053-F662850A60BB","latestVersionIndicator":"Yes","beginDate":"2019-08-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-08-12","modifiedBy":"SOKKERL","dateModified":"2019-08-13","changeDescription":"8/12/19 Cohort study 10287 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}